LifeMD Review

LifeMD: a publicly traded, brand-only GLP-1 program

LifeMD is one of the few weight-loss telehealth companies you can actually look up on the stock market — it's a publicly traded, 50-state direct-to-patient operation, not a here-today storefront. That matters more than it sounds. It means there's a real corporate entity behind your care, financial reporting it has to answer for, and a long-game incentive to keep the lights on. For people who feel uneasy handing their health to an anonymous brand they've never heard of, that visibility is the whole pitch. The catch: LifeMD has made a deliberate choice to prescribe brand-name GLP-1 medications only, which puts it on the pricier end of this market by design.

How the money actually works (it's a two-part bill)

This is the single most important thing to understand before you sign up, because LifeMD's pricing isn't one number — it's two. You pay a monthly program and provider fee of $149, dropped to $75 for your first month, and that fee is completely separate from the cost of the medication itself. The program fee buys you the clinical wrapper: the prescribing clinician, ongoing visits, coaching, and lab work. The drug is billed on top of that.

For the medication, here's roughly what you're looking at: the semaglutide brand options run from a low-three-figure monthly cost for the Wegovy oral pill up around a couple hundred dollars for the Wegovy pen, and the tirzepatide Zepbound vial sits higher still in the mid-three-figures per month. The genuinely good news is hidden in the fine print: if you have commercial insurance, LifeMD says the brand medication can drop to as little as a single-digit-to-low-double-digit monthly copay. That's the scenario where this program goes from expensive to a real bargain.

What you're paying the program fee for

Unlike bargain compounding shops where you mostly pay for a vial and a quick rubber-stamp, LifeMD's monthly fee is bundling in actual services. The program includes:

• Expert clinician consultations — physician-supervised, not a one-and-done questionnaire
• Dedicated coaching to support the behavior-change side of weight loss
• Essential lab work, if you haven't had it done in the last 12 months
• Personalized prescriptions and ongoing dose management

Notably, labs and coaching being baked in is something a lot of cheaper competitors skip or charge extra for. If you value the supervision and don't want to chase down your own bloodwork, you're getting something for that recurring fee beyond a prescription.

Brand-name only — the deliberate trade-off

Here's where LifeMD splits the audience. It dispenses real, FDA-approved branded medications — Wegovy as both an injection pen and the newer oral pill, plus Zepbound and Mounjaro — and pointedly does not offer a lower-cost compounded version. Many rivals lead with compounded semaglutide or tirzepatide at a fraction of the price. LifeMD has decided not to play that game.

If you're cash-pay and uninsured, that decision will sting — you're paying brand prices with no budget escape hatch, and the category median program cost of $170 doesn't capture the medication bill stacked on top. But if you have commercial insurance, or you simply trust an FDA-approved branded pen over a compounded formulation, the same decision is exactly what you want. There's no ambiguity about what's in the vial.

Who should choose LifeMD — and who should skip it

Choose LifeMD if you have commercial insurance that covers GLP-1s (the copay path is the best-case scenario here), if you specifically want brand-name Wegovy or Zepbound rather than a compound, or if the reassurance of a publicly traded, 50-state company with built-in labs and coaching is worth a premium to you. The oral Wegovy pill option is also a genuine draw for anyone who'd rather not inject.

Skip it if you're paying entirely out of pocket and chasing the lowest possible monthly cost — a compounding-focused provider will be dramatically cheaper, and LifeMD has no answer to that on price. Also weigh the two-part bill honestly: the program fee is real money every month whether or not your insurance helps with the drug.

Trust and oversight

On the safety ledger, LifeMD looks clean. There are no FDA warning letters on file in our record, the program is physician-supervised, and operating as a publicly traded 50-state company means a level of corporate accountability most telehealth startups can't match. Because it sticks to FDA-approved branded drugs, you also sidestep the quality-control questions that hang over some compounded supply chains. One practical caveat from the record: state licensing rules can vary, so a specific medication or service may not be available at every intake — confirm your options for your state when you sign up. You can see how we weigh these factors in our scoring methodology.

The bottom line

LifeMD is the insured patient's GLP-1 program. If your commercial plan covers the medication, the combination of a modest copay, a credible publicly traded operator, and included labs and coaching is genuinely hard to beat — and the $75 first month lowers the cost of finding out. If you're uninsured and price-sensitive, the brand-only stance makes it one of the more expensive routes to the same molecules, and you'll likely be happier with a compounding provider. Know which patient you are before you enroll, and the $149 monthly fee will make a lot more sense.